Research assessing predictors of preventive screening often focuses on individual patient factors, despite known relationships between neighborhood environment and health. Using a retrospective cohort study of 519,826 patients meeting US Preventive Service Task Force guideline recommendation for screening for prediabetes and type 2 diabetes (age 35-70 years and BMI ≥25) from Kaiser Permanente Northern California in 2018, we used logistic regression to assess the relationship between diabetes screening and census neighborhood tract-level measures, and area gentrification measures developed by the Urban Displacement Project, controlling for age, sex, race, ethnicity, and BMI. Thirty-eight percent of patients were screened for diabetes. Patients aged 60-70 years had higher odds of diabetes screening compared to patients aged 35-39 years (OR: 2.73, 95% CI: 2.67-2.78) . Men had lower odds of screening compared to women (OR: 0.91, 0.90-0.92) . Asian patients had higher odds of screening compared to White patients (OR 1.44, 1.42-1.46) . Patients with BMI ≥40 had higher odds of screening compared to patients with BMI 25-29.9 (OR: 1.34, 1.30-1.37) . Patients living in census tracts with the lowest median values of homes (OR: 0.93, 0.90-0.96) and with the lowest median household income (OR: 0.95, 0.91-0.99) had lower odds of diabetes screening compared to those in census tracts with the highest values. Patients living in census tracts classified as Ongoing Displacement/Low Income Susceptible to Displacement had lower odds of screening (OR: 0.96, 0.93-0.98) compared to those living in stable moderate mixed income tracts. We found insufficient screening rates and that gentrification and area-level socioeconomic factors were associated with lower diabetes screening, even after adjusting for individual demographic and clinical factors. Health care systems should consider addressing social needs and community resources as a path to improving preventive care.

Disclosure

T.Thomas: None. W.T.Dyer: None. L.A.Rodriguez: None. J.Schmittdiel: None.

Funding

Kaiser Permanente Northern California Community Benefit Programs; The Permanente Medical Group (TPMG) Delivery Science Fellowship Program; National Institute of Diabetes and Digestive and Kidney Diseases grant T32DK11668401. Dr. Schmittdiel received additional support from the NIDDK-funded Health Delivery Systems Center for Diabetes Translational Research (1P30 DK92924) .

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.